Horn Kinney 4
4 · Olema Pharmaceuticals, Inc. · Filed Dec 14, 2021
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-10$2.06/sh+5,251$10,838→ 7,709 total - Sale
Common Stock
2021-12-10$10.39/sh−5,251$54,558→ 2,458 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-10−5,251→ 157,540 totalExercise: $2.06Exp: 2030-06-09→ Common Stock (5,251 underlying)
Footnotes (4)
- [F1]Includes 668 shares acquired under the issuer's Employee Stock Purchase Plan on November 15, 2021.
- [F2]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F3]The weighted average sale price for the transaction reported was $10.39, and the range of prices were between $10.18 and $11.11. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F4]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.